1 Growth Stock That Could Turn $1,000 Into $2,500 by 2030

Growth stocks are back in style after getting hammered in 2022, and many investors are rushing to buy shares of recovering growth-oriented companies. After crushing the market over the past year, Eli Lilly has what it takes to do it all over again. Here's why the company could turn an initial investment of $1,000 into $2,500 by 2030 — a compound annual growth rate (CAGR) of nearly 16%.